| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.007 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.093 | 0.007 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.15 | 0.007 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.43 | 0.008 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.15 | 0.009 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.009 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.009 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.14 | 0.009 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |